Skip to main content
Figure 1 | BMC Physiology

Figure 1

From: High calcium and dobutamine positive inotropy in the perfused mouse heart: myofilament calcium responsiveness, energetic economy, and effects of protein kinase C inhibition

Figure 1

A. Developed pressure at perfusate calcium 1.5 – 3.5 mM and with dobutamine (dob, 0.9 μM). B. Peak systolic intracellular calcium, C. Myocardial oxygen consumption (MVO2), D. Ratio of developed pressure to myocardial oxygen consumption (DP/ MVO2). Symbols for Figure 1A: * p < 0.005 vs perfusate calcium 2.0, 2.5, 3.5 mM and dobutamine; † p < 0.05 vs dobutamine and perfusate calcium 3.5 mM; §p < 0.0001 vs dobutamine; ** p < 0.05 vs dobutamine; Symbols for Figure 1B:* p < 0.005 vs perfusate calcium 3.5 mM and dobutamine; † p < 0.05 vs perfusate calcium 3.5 mM and dobutamine; Symbols for Figure 1C: p = 0.05 vs dobutamine; § p < 0.05 vs dobutamineSymbols for Figure 1D:* p < 0.0001 vs perfusate calcium 2.0, 2.5, 3.5 mM and dobutamine; † p < 0.0001 vs dobutamine; §p < 0.0005 vs dobutamine; ** p < 0.05 vs dobutamine

Back to article page